Related Experiment Video
Updated: Jun 1, 2026

A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites
Published on: August 8, 2014
[Chronic inflammation and biomarkers. Is ageing an expression of chronic inflammation?]
D Schmidt1, A Kwetkat, M Gogol
1Klinik für Geriatrie, Krankenhaus Lindenbrunn, Lindenbrunn 1, Coppenbrügge, Germany. geriatrie@krankenhaus-lindenbrunn.de
Insights
Aging variability is linked to cardiovascular disease and chronic inflammation, termed "inflammageing". Biomarkers like C-reactive protein and interleukin-6 are associated, but inflammageing
Area of Science:
- Gerontology and immunology.
- Cardiovascular disease research.
Context:
- Aging exhibits significant interindividual and intraindividual variability.
- Subclinical and clinical cardiovascular diseases are known accelerators of the aging process.
- The concept of "inflammageing" proposes aging as a chronic inflammatory process.
Purpose:
- To explore the relationship between cardiovascular diseases, inflammation, and the aging process.
- To discuss the role of various biomarkers in the context of inflammageing.
- To evaluate the potential of inflammageing as a model for aging and its prognostic utility.
Summary:
- Aging is characterized by variability and accelerated by cardiovascular diseases, suggesting a link to chronic inflammation or "inflammageing".
- Biomarkers such as C-reactive protein (CRP), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), fibrinogen, albumin, and serum amyloid A (SAA) are associated with inflammageing.
- Connections are observed with immunosenescence, viral infections, oxidative stress markers, and genetic factors.
Impact:
- Current evidence suggests inflammageing biomarkers are not yet definitive for determining aging or prognosis.
- Further research is required to validate inflammageing as a comprehensive model for aging or as a consequence of other mechanisms.
- Understanding inflammageing may offer new insights into age-related diseases and interventions.
Abstract:
Ageing shows a high interindividual and intraindividual variability. Subclinical and clinical cardiovascular diseases accelerate the ageing process in part and in total. This leads to the idea that ageing is a result of a chronic inflammation process and to the term "inflammageing". A variety of biomarkers (e.g. C-reactive protein, interleukin-6, tumor necrosis factor alpha, fibrinogen, albumin and serum amyloid A) are described in this context. Furthermore there is a relationship to changes in the immune system across the lifespan (immunosenescence), viral infections, the occurrence of markers of oxidative stress and genetic changes. At this point in time the role for determining ageing and its use as a prognostic tool seems to be impossible. Whether inflammageing is a valid model for describing the ageing process or is the consequence of other mechanisms needs further discussion.
Related Concept Videos
Chronic Inflammation: Introduction
Inflammation
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
The Effect of Aging on Tissues
Inflammatory Bowel Disease III: Crohn's Disease
